1 / 4

Clinical Outcomes of the RECORD Study: Effects on HbA1c and Glucose Control in Diabetes

The RECORD Study investigates the clinical and baseline characteristics of the diabetic population over an 18-month treatment period. Key metrics include the time course of HbA1c levels and fasting plasma glucose (FPG). The study also examines changes from baseline in glucose control, insulin sensitivity, body weight, and inflammatory markers. Findings contribute to understanding the impact of diabetes management strategies on patient outcomes, including metabolic control and associated health factors.

carolos-alex
Télécharger la présentation

Clinical Outcomes of the RECORD Study: Effects on HbA1c and Glucose Control in Diabetes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RECORD Study: Flow diagram P. D. Home, Diabet Med 2007;24:626-34

  2. RECORD Study: Clinical and baseline characteristics of the population studied P. D. Home, Diabet Med 2007;24:626-34

  3. Time course for HbA1c (upper panels) and fasting plasma glucose (FPG; lower panels) during the 18-month treatment period P. D. Home, Diabet Med 2007;24:626-34

  4. Change from baseline at 18 months in measures of glucose control, insulin sensitivity, body weight, inflammatory/thrombotic markers and lipid measures P. D. Home, Diabet Med 2007;24:626-34

More Related